Bristol-Myers Squibb Co. has bolstered its immuno-oncology ambitions by acquiring IL-8 focused Cormorant Pharmaceuticals AB, the 4-year old Swedish biotech. Cormorant’s shareholders are getting $95M up front with the promise of a further $425M if milestones are achieved.

Imagine wearing a belt containing an airbag that activates when you begin to fall, thus cushioning you from a hip fracture. ActiveProtective Technologies Inc. is developing just such a device that targets the frail and elderly population.

Laboratoires Nutrition et Cardiométabolisme aims to combat obesity and metabolic disease with a range of prescription-only medical nutrition products.

Laboratoires Nutrition et Cardiométabolisme aims to combat obesity and metabolic disease with a range of prescription-only medical nutrition products.